ATE114114T1 - Verwendung von benzimidazol-derivaten als antibakterielle mittel. - Google Patents

Verwendung von benzimidazol-derivaten als antibakterielle mittel.

Info

Publication number
ATE114114T1
ATE114114T1 AT90301256T AT90301256T ATE114114T1 AT E114114 T1 ATE114114 T1 AT E114114T1 AT 90301256 T AT90301256 T AT 90301256T AT 90301256 T AT90301256 T AT 90301256T AT E114114 T1 ATE114114 T1 AT E114114T1
Authority
AT
Austria
Prior art keywords
antibacterial agents
benzimidazole derivatives
stands
hydrogen
campylobacter
Prior art date
Application number
AT90301256T
Other languages
English (en)
Inventor
Tomoyuki Iwahi
Hiroshi Satoh
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26370930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE114114(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE114114T1 publication Critical patent/ATE114114T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
AT90301256T 1989-02-10 1990-02-06 Verwendung von benzimidazol-derivaten als antibakterielle mittel. ATE114114T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3237489 1989-02-10
JP23923389 1989-09-15

Publications (1)

Publication Number Publication Date
ATE114114T1 true ATE114114T1 (de) 1994-12-15

Family

ID=26370930

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90301256T ATE114114T1 (de) 1989-02-10 1990-02-06 Verwendung von benzimidazol-derivaten als antibakterielle mittel.

Country Status (10)

Country Link
US (1) US5013743A (de)
EP (1) EP0382489B1 (de)
AT (1) ATE114114T1 (de)
CA (1) CA2009741C (de)
DE (1) DE69014141T2 (de)
DK (1) DK0382489T3 (de)
ES (1) ES2066120T3 (de)
FI (2) FI100168B (de)
GR (1) GR3014973T3 (de)
NO (1) NO900639L (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338723A (en) * 1989-10-13 1994-08-16 Merck & Co., Inc. Fibrinogen receptor antagonists
ES2169022T3 (es) * 1990-09-14 2002-07-01 Byk Gulden Lomberg Chem Fab Utilizacion de derivados de (piridil-metil-sulfinil)-1-h-bencimidazol para el tratamiento de enfermedades provocadas por helicobacter.
TW209174B (de) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
IS3990A (is) * 1992-04-24 1993-10-25 Ab Astra Aðferð við að blanda saman efni sem hindrar flæðimagasýru og bakteríueyðandi efnis sem brotnar niður í súru umhverfi
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
CA2138787A1 (en) * 1992-07-08 1994-01-20 Clifton Augustus Baile Alleviating stomach ulcers in swine
US5589491A (en) * 1992-07-28 1996-12-31 Astra Aktiebolag Injection and injection kit containing omeprazole and its analogs
ES2087623T3 (es) * 1992-08-21 1996-07-16 Eisai Co Ltd Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.
EP0673246A1 (de) * 1992-12-10 1995-09-27 Byk Gulden Lomberg Chemische Fabrik GmbH Verwendung von alkylthiopyridinen zur bekämpfung von heliobacter-bakterien
JPH06298611A (ja) * 1993-04-16 1994-10-25 Nippon Chemiphar Co Ltd 抗菌剤
JPH08512037A (ja) * 1993-06-29 1996-12-17 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換されたアリールチオアルキルチオピリジン
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
CA2317439A1 (en) 1998-01-14 1999-07-22 Wayne J. Brouillette Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
FI104384B (fi) 1998-06-05 2000-01-14 Valmet Corp Laitteisto ja menetelmä viiraveden ja tuoremassan sekoittamiseksi viirakaivon jälkeisessä kanavassa
US7396841B2 (en) 2000-08-18 2008-07-08 Takeda Pharmaceutical Company Limited Injections
KR20040025677A (ko) * 2001-09-18 2004-03-24 제리아 신야쿠 고교 가부시키 가이샤 벤즈이미다졸 유도체
US9358214B2 (en) * 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
MXPA04007169A (es) * 2002-01-25 2004-10-29 Santarus Inc Suministro transmucosal de inhibidores de bomba de protones.
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
TWI398273B (zh) * 2003-07-18 2013-06-11 Santarus Inc 用於抑制酸分泌之醫藥調配物及其製備及使用之方法
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
MXPA06000524A (es) * 2003-07-18 2006-08-11 Santarus Inc Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido.
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
EP1718303A4 (de) * 2004-02-10 2010-09-01 Santarus Inc Kombination eines protonenpumpenhemmers, puffermittels und einem nichtsteroidalen entzündungshemmenden mittel
AU2005249367A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
CA2624179A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
ATE533757T1 (de) * 2006-03-10 2011-12-15 Arigen Pharmaceuticals Inc Neues pyridinderivat mit wirkung gegen helicobacter pylori
CA2654402A1 (en) * 2006-06-01 2007-12-06 Adel Penhasi Multiple unit pharmaceutical formulation
JP2009539866A (ja) * 2006-06-05 2009-11-19 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換エリスロマイシンアナログの調製および有用性
WO2008067037A2 (en) 2006-10-05 2008-06-05 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
JP5543432B2 (ja) * 2009-04-09 2014-07-09 リンク・ジェノミクス株式会社 ピリジンチオ誘導体及びそれを含有する抗ヘリコバクター・ピロリ作用を有する医薬組成物
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
US20110212171A1 (en) * 2010-01-08 2011-09-01 Eurand, Inc. Taste masked topiramate composition and an orally disintegrating tablet comprising the same
EP3288556A4 (de) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Oral zerfallende zusammensetzungen
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP4598528A1 (de) 2022-10-04 2025-08-13 Arsenil Zabirnyk Hemmung der verkalkung der aortenklappe

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JP2694361B2 (ja) * 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤

Also Published As

Publication number Publication date
FI940951A0 (fi) 1994-02-28
ES2066120T3 (es) 1995-03-01
CA2009741A1 (en) 1990-08-10
FI104045B1 (fi) 1999-11-15
US5013743A (en) 1991-05-07
EP0382489A3 (de) 1991-06-12
NO900639L (no) 1990-08-13
DE69014141D1 (de) 1994-12-22
EP0382489A2 (de) 1990-08-16
NO900639D0 (no) 1990-02-09
FI100168B (fi) 1997-10-15
FI940951L (fi) 1994-02-28
EP0382489B1 (de) 1994-11-17
DE69014141T2 (de) 1995-05-24
FI900662A0 (fi) 1990-02-09
GR3014973T3 (en) 1995-05-31
DK0382489T3 (da) 1995-01-16
CA2009741C (en) 1999-03-23
FI104045B (fi) 1999-11-15

Similar Documents

Publication Publication Date Title
DE69014141D1 (de) Verwendung von Benzimidazol-Derivaten als antibakterielle Mittel.
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
NZ228893A (en) Substituted quinoline and naphthyridine derivatives and pharmaceutical compositions
BG106390A (en) Novel spiro compounds
ATE82966T1 (de) Pyridincarboxamid-derivate und ihre verwendung als fungizides mittel.
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
ATE227277T1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
PT867436E (pt) Derivados de n-aril-piperidina e sua utilizacao como ligandos do receptor 5-ht1b
NO934718L (no) Nye HIV protease inhibitorer
DE69231422D1 (de) Pyridoncarbonsäurederivate
ATE159728T1 (de) Cis-epoxide derivate, verwendbar als irreversible hiv-protease inhibitoren und verfahren und zwischenprodukte zu ihrer herstellung
YU83993A (sh) Novi derivati piridon organske kiseline
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
ATE209633T1 (de) Pyridinderivate,als arzneimittel zur behandlung von geschwüren und als antibakterielle mittel
MXPA02011234A (es) Nuevas bases de oxidacion 2,5-diaminopiridina utiles para el tinte de las fibras queratinicas.
ATE279191T1 (de) Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
DE69017627D1 (de) Isochinolinderivate und ihre Salze als Proteasehemmer.
ATE275560T1 (de) Bemzimidazolverbindungen und medikamente die diese enthalten
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ATE222255T1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel
ATE141918T1 (de) Isoquinolinderivate
ES2090056T3 (es) Derivados de pirroloquinolina, su utilizacion como agentes antimicrobianos y procedimientos para su preparacion.